We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$578M
AUM Growth
+$21.8M
Cap. Flow
-$3.17M
Cap. Flow %
-0.55%
Top 10 Hldgs %
71.9%
Holding
76
New
5
Increased
14
Reduced
44
Closed
1

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.76M
2
GILD icon
Gilead Sciences
GILD
+$1.83M
3
VTRS icon
Viatris
VTRS
+$1.34M
4
XOM icon
ExxonMobil
XOM
+$1.17M
5
CAH icon
Cardinal Health
CAH
+$1.11M

Sector Composition

Rank Sector Weight
1 Financials 41.39%
2 Technology 16.55%
3 Energy 14.38%
4 Healthcare 13.57%
5 Consumer Staples 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$205M 35.48%
575,250
-1,213
-0.2% -$426K
XOM icon
2
ExxonMobil
XOM
$658B
$52.5M 9.08%
525,249
-11,136
-2% -$1.17M
INTC icon
3
Intel
INTC
$460B
$51.6M 8.92%
1,026,333
-8,276
-0.8% -$336K
QCOM icon
4
Qualcomm
QCOM
$172B
$26.3M 4.55%
181,786
-2,316
-1% -$287K
OXY.WS icon
5
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$25M 4.32%
641,854
+64,812
+11% +$2.54M
JNJ icon
6
Johnson & Johnson
JNJ
$652B
$12M 2.08%
76,841
-1,231
-2% -$189K
OGN icon
7
Organon & Co
OGN
$3.61B
$11.6M 2%
803,097
+43,706
+6% +$595K
WBA
8
DELISTED
Walgreens Boots Alliance
WBA
$11.1M 1.92%
425,226
+87,660
+26% +$1.96M
ALLY icon
9
Ally Financial
ALLY
$13B
$10.9M 1.89%
312,303
-11,068
-3% -$309K
COP icon
10
ConocoPhillips
COP
$159B
$9.63M 1.66%
82,955
-1,025
-1% -$120K
AMGN icon
11
Amgen
AMGN
$239B
$8.8M 1.52%
30,567
-4,034
-12% -$1.1M
BAC icon
12
Bank of America
BAC
$436B
$8.52M 1.47%
253,062
-62
-0% -$1.8K
GILD icon
13
Gilead Sciences
GILD
$184B
$7.83M 1.35%
96,633
-23,560
-20% -$1.83M
VTRS icon
14
Viatris
VTRS
$19.3B
$7.7M 1.33%
711,349
-139,703
-16% -$1.34M
OXY icon
15
Occidental Petroleum
OXY
$58.7B
$7.26M 1.25%
121,536
-8,274
-6% -$505K
USB icon
16
US Bancorp
USB
$98.3B
$7.25M 1.25%
167,431
-6,368
-4% -$233K
MO icon
17
Altria Group
MO
$115B
$7.02M 1.21%
174,026
+12,802
+8% +$529K
FDX icon
18
FedEx
FDX
$80.3B
$6.41M 1.11%
25,320
-553
-2% -$140K
BABA icon
19
Alibaba
BABA
$288B
$5.89M 1.02%
76,022
-47,225
-38% -$3.76M
CVX icon
20
Chevron
CVX
$395B
$5.83M 1.01%
39,075
+1,814
+5% +$274K
KHC icon
21
Kraft Heinz
KHC
$29.2B
$5.63M 0.97%
152,370
+679
+0.4% +$23.1K
PFE icon
22
Pfizer
PFE
$162B
$5M 0.86%
173,535
+155,355
+855% +$4.7M
LLY icon
23
Eli Lilly
LLY
$1.06T
$4.94M 0.85%
8,475
-325
-4% -$190K
MRK icon
24
Merck
MRK
$378B
$4.89M 0.85%
44,860
-1,025
-2% -$106K
IBM icon
25
IBM
IBM
$217B
$4.79M 0.83%
29,267
-2,860
-9% -$432K

Similar funds

Greylin Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Greylin Investment Management held 76 positions worth $578M, up 3.9% from $557M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Greylin Investment Management's Q4 2023 filing shows 5 new, 14 increased, 44 reduced and 1 closed positions. Its largest new stake was CrossFirst Bankshares, Inc. Common Stock: 39,500 shares worth $536K. The largest sale was Alibaba, an estimated $3.76M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Technology and Energy.

  • Greylin Investment Management's largest Q4 2023 buy was CrossFirst Bankshares, Inc. Common Stock: 39,500 shares worth $536K.
  • Greylin Investment Management added most to Pfizer in Q4 2023, an estimated $4.7M increase.
  • Greylin Investment Management's biggest Q4 2023 reduction was Alibaba, cutting an estimated $3.76M.
  • Greylin Investment Management fully exited PayPal in Q4 2023, selling an estimated $890K.
  • Greylin Investment Management's ten largest holdings make up 72% of its $578M portfolio in Q4 2023.
  • Greylin Investment Management opened 5 new positions and closed 1 in Q4 2023.
  • Greylin Investment Management's portfolio value rose 3.9% quarter-over-quarter to $578M.

Based on Greylin Investment Management's 13F filing for Q4 2023, filed 26 Jan 2024.